Avoro Capital Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $810M | Hold |
|
|||||
|
2023
Q2 | $720M | Hold |
|
|||||
|
2023
Q1 | $764M | Hold |
|
|||||
|
2022
Q4 | $797M | Buy |
|
|||||
|
2022
Q3 | $317M | Buy |
|
|||||
|
2022
Q2 | $399M | Sell |
|
|||||
|
2022
Q1 | $684M | Sell |
|
|||||
|
2021
Q4 | $1B | Buy |
|
|||||
|
2021
Q3 | $986M | Hold |
|
|||||
|
2021
Q2 | $843M | Hold |
|
|||||
|
2021
Q1 | $828M | Hold |
|
|||||
|
2020
Q4 | $658M | Buy |
|
|||||
|
2020
Q3 | $594M | Buy |
|
|||||
|
2020
Q2 | $333M | Buy |
|
|||||
|
2020
Q1 | $136M | Buy |
|
|||||
|
2019
Q4 | $145M | Hold |
|
|||||
|
2019
Q3 | $109M | Hold |
|
|||||
|
2019
Q2 | $96.2M | Hold |
|
|||||
|
2019
Q1 | $106M | Sell |
|
|||||
|
2018
Q4 | $85M | Sell |
|
|||||
|
2018
Q3 | $87.3M | Sell |
|
|||||
|
2018
Q2 | $92.6M | Buy |
|
|||||
|
2018
Q1 | $73.3M | Buy |
|
|||||
|
2017
Q4 | $64.8M | Buy |
|
|||||
|
2017
Q3 | $44.6M | Buy |
|